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the target lesion during long-term follow-up, DM was associated with significantly
increased other major cardiac ischemic events and a non-statistically significant increase
in mortality. 
1081-55 Influence of Gender on In-Hospital and Long-Term 
Clinical Outcomes Following Percutaneous or Surgical 
Revascularization: A Report From the Arterial 
Revascularization Therapies Study (ARTS)
Vassilis Voudris, Dennis V. Cokkinos, Clemens Disco, Patrick W. Serruys, on Behalf of 
Arterial Revascularization TherapiesStudy (ARTS) Group, Onassis Cardiac Surgery 
Center, Athens, Greece, Thoraxcenter and Cardialysis, Rotterdam, The Netherlands
Background: Previous studies have shown that women (W) undergoing coronary revas-
cularization (CR) have a higher incidence of in-hospital complications than men (M). To
determine whether W have an unfavorable long-term outcome after percutaneous (PCI)
or surgical (CABG) CR compared with M, we evaluated patients (pts) enrolled within the
Arterial Revascularization Therapies Study (ARTS).
Methods: We prospectively evaluated 1205 pts with angina or silent ischemia and multi-
vessel (MV) disease randomized to PCI or CABG of whom 283 (23%) were W. The clini-
cal presentation, in-hospital complications and the freedom from major adverse cardiac
and cerebrovascular events at 3-years were evaluated.
Results: W were older (65 vs 59 years), with a higher prevalence of hypertension (59%
vs 40%, p(less)0.001), hypercholestelolemia (71% vs 54%, p(less)0.001), family history
for coronary artery disease (52% vs 37%, p(less)0.001) and stable angina (64% vs 57%,
p=0.03) than M, but had a lower incidence of history of myocardial infarction (35% vs
46%, p(less)0.001) or current smoking (18% vs 30%, p(less)0.001). The presence of
unstable angina, the extent of coronary artery disease and the location of the stenosis
was similar in W and M. W assigned to CABG received the same number of arterial con-
duits and had similar number of distal anastomoses compared to M (2.5+0.7 vs 2.5+0.7
and 2.6+1.0 vs 2.8+1.1 respectively, p:ns). A higher incidence of in-hospital death (3.2%
vs 0.5%, p=0.001) and major bleeding complications (4.2% vs 1.5%, p=0.01) were
observed in W compared to M, because of increased mortality in W post-CABG
(CABG=4.1%, PCI=2.17%) and bleeding events following PCI (PCI=7.2%,
CABG=1.38%). At an average of 3 years follow-up the survival without death / cere-
brovascular accident / myocardial infarction / revascularization was similar in M and W.
(M : PCI=66.2%, CABG=83.9% ; W : PCI = 64.5%, CABG=81.4%).
Conclusion:The 3 year outcomes of W with MV disease undergoing CR are similar to
those in M. Despite the similarity in long-term outcomes, there are several gender-spe-
cific differences in clinical characteristics and risk factors profile resulting in higher in-hos-
pital complications in W.
1081-56 Evolution of Percutaneous Coronary Intervention in 
Acute Myocardial Infarction: Insights From a Large 
Single Center Database
Gunasekaran Sengottuvel, Thierry Lefèvre, Yves Louvard, Pierre Dumas, Mehran 
Monchi, Christophe Loubeyre, Oscar Tavolaro, Marie-Claude Morice, Institut 
Cardiovasculaire Paris Sud, Massy, France
Background: Over the last several years, the number of PCI in acute myocardial infarc-
tion (AMI) has increased and stent has become an established gold standard with
increased use of Gp2b3a inhibitors as an adjunctive therapy and facilitated PCI is being
currently evaluated. The objectives of this study is to assess the evolution and trends of
PCI in AMI over the last eight years from a single center prospective registry.
Methods: Our registry started in January 1995 with pre defined strategy in AMI < 12
hours: no contra-indication regarding pre-hospital thrombolysis, direct admission in the
cathlab for immediate coronary angiogram, angioplasty when indicated and stent when
feasible.
Results: From 1995 to 2002, a total of 1824 consecutive patients underwent PCI in AMI.
They were 61.8+14.4 years, 78% males, 17% diabetes mellitus, 12% previous MI, 45%
anterior MI and 13% in cardiogenic shock. Evolution is summarized below. 
Conclusion: From 1995 to 2002, progress in PCI in AMI is remarkable with significant 
increases in pre-hospital thrombolysis, radial approach, glycoprotein IIb/IIIa inhibitors, 
stents and direct stenting. Outcome improved markedly with higher final TIMI 3 flow and 
reduced death and re-intervention.
1081-57 Randomized Comparison Between Stent and Balloon in 
Diabetic With ST-Segment Elevation Myocardial 
Infarction Undergoing Primary Angioplasty: A Substudy 
of the Zwolle-6 Randomized Trial
Giuseppe De Luca, Harry Suryapranata, Felix Zijlstra, Jan Paul Ottervanger, Arnoud WJ 
van't Hof, Jan-Henk E Dambrink, AT Marcel Gosselink, Jan CA Hoorntje, Menko-Jan de 
Boer, De Weezenlanden Hospital, Zwolle, The Netherlands
Background. Currently available randomized trials on primary stenting for ST-segment
elevation myocardial infarction (STEMI), have enrolled highly selected patients, after the
initial angiogram. In the Zwolle 6 randomized trial, 1683 patients with STEMI were ran-
domized, before angiography, to stent (S) or balloon (B), without any exclusion criteria. In
this study we present data from the subanalysis conducted in diabetic patients. 
Methods. Among a total of 1683 consecutive patients with STEMI enrolled in the study,
177 (10.5%) suffered from diabetes (S = 94 and B = 83). The primary endpoint was
MACE (death, reinfarction, and/or reintervention at 1-year).
Results. The cross-over rates from B to S and S to B were 30.3% and 20.2%, respec-
tively. No difference was observed in 1-year mortality and MACE according to intention-
to-treat analysis (see figure).
Conclusions. Our study is the first randomized trial comparing stenting and balloon
angioplasty in a large cohort of unselected, consecutive patients. This subanalysis
showed that routine stenting does not improve clinical outcome in diabetic patients
undergoing primary angioplasty for STEMI. 
1081-58 Long-Term (Seven-Year) Outcomes After Bare Metal 
Coronary Stenting for Unprotected Left Main Coronary 
Stenosis
Shinichi Shirai, Kenji Ando, Kei Nishiyama, Takashi Yamada, Jiro Ando, Masashi 
Iwabuchi, Hiroyoshi Yokoi, Hideyuki Nosaka, Masakiyo Nobuyoshi, Kokura Memorial 
Hospital, Kitakyushu, Japan
Background) Drug eluting stent may spread the indication of coronary intervention.
Therefore, the longer-term efficacy of bare metal coronary stenting for unprotected left
main coronary artery (LMCA) stenosis is necessary to be evaluated.
Methods) Between March 1991 and August 1996, 36 consecutive patients (pts) with
unprotected LMCA stenosis underwent elective stenting. Treated pts were divided into 2
groups; good candidate group (GC:17pts) for coronary artery bypass grafting(CABG),
and poor candidate group (PC 19pts) with risk factors; old age (>75 yrs) in 8pts, cere-
brovascular disease in 7 pts, prior CABG in 5 pts, poor LV (ejection fraction<40%) in 2
pts, COPD in 1 patient (pt), cancer in 1 pt, and poor run off in 1 pt. Clinical follow-up was
performed with mean interval of 64±36 months.
Results) The procedure success rate was 100%. 3-6month angiographic follow-up was
performed in 34 pts, and the restenosis rate was 21% (7/34). During the follow-up period,
thirteen pts were died (3 cardiac, 10 noncardiac). Estimated event free rate from cardiac
Endpoint Diabetes
N=263
No Diabetes
N=965
P
One-Year Outcomes
Composite 33.1% 24.6% <0.01
Death 1.1% 0.8% >0.20
MI 9.5% 7.6% >0.20
TLR 16.9% 11.0% 0.02
Other Revascularization 27.2% 19.0% <0.01
Five-Year Outcomes
Composite 58.5% 42.8% <0.01
Death 10.4% 7.7% 0.14
MI 12.2% 9.7% >0.20
Death or MI 20.9% 16.9% 0.08
New unstable angina 7.6% 4.3% 0.03
New onset CHF 3.4% 1.0% <0.01
TLR 23.2% 16.7% 0.02
Other Revascularization 34.0% 24.9% <0.01
1995-96 1997-98 1999-2000 2001- 02
Prehospital thrombolysis (% ) 13 18 18 31
GP IIbIIIa (% ) 0 5 10 11
Stent (%)
Direct Stenting (%)
84
10
90
14
92
47
95
67
Radial approach (% ) 2 10 39 55
Angiographic success (% ) 99 99 100 100
Final TIMI 3 (%) 89 89 92 95
Repeat PTCA (%) 7.0 2.9 2 2.4
In hospital Death (%) 13 10 8 8
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death at 7-year was 91% (94% in GC group, 88% in PC group),and free from MACE (car-
diac death/ CABG/ myocardial infarction/ TLR) was 71% (81% in GC group, 62% in PC
group).
Conclusion) Bare metal coronary stent treatment for unprotected LMCA stenosis had a
favorable longer-term follow up result, particularly in low CABG risk group. 
1081-59 Target Vessel Revascularization During the First Month 
After Bare Metal Coronary Stenting: Clinical Indications 
and Angiographic Findings
Prabhakara S. Heggunje, Renney Abraham, Amr Abbas, Surjya Das, Stacy Brewington, 
Simon R. Dixon, William W. O'Neill, Cindy L. Grines, William Beaumont Hospital, Royal 
Oak, MI
Background: Patients who undergo target vessel revascularization (TVR) during the first
4 weeks after coronary stenting are assumed to have subacute stent thrombosis (SAT).
However, other factors may account for TVR during this period. We studied the angio-
graphic findings and clinical indications for TVR within the first month after coronary
stenting.
Methods: We reviewed the clinical and angiographic data of all patients who underwent
TVR within the first month after coronary stenting at our hospital between February 1995
and July 2003. Vein graft interventions were excluded.
Results: Of the 21,433 patients who underwent coronary stenting, 266 (1.24 %) had TVR
within the first month. Clinical indications and angiographic findings are shown in table 1.
The majority of patients presented as ST elevation MI or unstable angina. SAT was seen
in 41% of patients, 24% had edge dissection, while 33% had untreated or new significant
lesions. Patients with AMI and hemodynamic compromise were more likely to have SAT,
whereas patients who presented with unstable angina or positive myocardial perfusion
imaging (MPI) were more likely to have a significant untreated or new lesion.
Conclusions: SAT accounts for less than half the number of TVR within the first month.
Patients with SAT usually present with AMI or hemodynamic compromise. Edge dissec-
tions are infrequently found. Patients with unstable angina usually have new or untreated
lesions, which may be due to trauma to the target vessel during index intervention.
1081-60 High Rate of In-Stent Thrombosis in Cocaine Users 
Undergoing Coronary Stent Placement
Gudjon Karlsson, Jalees Rehman, Henry M. Meltser, Vijay G. Kalaria, Jeffrey A. Breall, 
Indiana University, School of Medicine, Indianapolis, IN
Introduction: Cocaine use has been associated with premature coronary artery disease
and myocardial infarction. Percutaneous revascularization and intracoronary stenting is
commonly performed in patients who actively use cocaine and have obstructive coronary
artery disease. The instent thrombosis rate in patients who undergo coronary stent
implantation and actively use cocaine is not known.
Methods: We reviewed all patients who underwent stent placement over an 18-month
period from 2002-2003 at an inner-city county hospital and identified patients with active
cocaine use, defined as a history of recent cocaine use or a positive toxicology screen for
cocaine. Angiograms of the patients who underwent repeat coronary angiography for
suspected myocardial ischemia or infarction were evaluated for stent thrombosis.
Results: Of a total of 247 patients who underwent coronary stent placement, 12 (4.9%)
were active cocaine users. All patients were prescribed standard dual antiplatelet therapy
after the index percutaneous revascularization procedure. Of these 12 patients, four
(33%) patients (mean age 55±8 years) presented with an acute myocardial infarction at a
mean of 51±40 days after the index revascularization procedure (average initial stent
diameter 2.88±0.14mm, and mean stent length 17.8±11 mm). Angiography confirmed
instent thrombosis and all of them underwent successful repeat percutaneous revascu-
larization.
Conclusions: Stent thrombosis in the modern era has been reported to be less than 1%
with dual anti-platelet therapy. We found a markedly higher (33%) incidence of thrombo-
sis in patients who actively use cocaine use and undergo percutaneous revasculariza-
tion. High rate of instent thrombosis in cocaine users may be due to a deleterious effect
of cocaine on the coronary endothelium impairing adequate stent endothelialization,
enhanced platelet aggregation and potential non-compliance with antiplatelet therapy.
Patients with active cocaine use who undergo coronary stenting warrant vigilant post-pro-
cedure follow-up and enrollement in a structured substance abuse program.
1081-61 Arterial Retroperfusion by a Percutaneous Stent-Based 
Ventricle to Coronary Vein Bypass (VVPASSTM)
Peter Boekstegers, Philip Raake, Martin Andrees, Sabrina Beller, Rabea Hinkel, Marie-
Luise von Brühl, Christian Kupatt, University Hospital Grosshadern, Munich, Germany
Background: Arterialization of coronary veins is a potential treatment modality in no
option patients. Chronic arterialization of coronary veins, however, is associated with an
increase of coronary venous pressure which might be complicated by hemorrhagic inf-
arction. A stent-based ventricle to vein bypass (VPASSTM) is an attractive new approach
to chronic venous arterialization trying to avoid chronic pressure overload due to passive
diastolic drainage of the vein after systolic retroperfusion. In this study, the efficacy of
vVPASSTM was compared to catheter-based pressure-regulated arterial retroinfusion
previously shown to maximize preservation of regional myocardial function during acute
ischemia.
Methods: In 8 pigs a retroinfusion catheter was placed in the anterior cardiac vein.
Regional myocardial function (sonomicrometry) was determined during LAD occlusion
with and without support by pressure-regulated retroinfusion. Thereafter, vVPASSTM was
established using a percutaneous ultrasound-guided puncture from the anterior cardiac
vein to the left ventricle with subsequent implantation of a ePTFE covered stent graft.
Results: After balloon occlusion of the LAD and of the proximal anterior cardiac vein,
venous pressure in the distal anterior cardiac vein increased to 70±2 mmHg (systolic)
resp. 58±2 mmHg (mean) compared to 57±3 mmHg resp. 50±2 mmHg during pressure-
regulated retroinfusion. Significant preservation of subendocardial segment shortening
(%baseline) was observed after vVPASSTM (66±10%) and during selective retroinfusion
(71±7%) compared to control LAD occlusion (5±5%). Conclusion: Percutaneous implan-
tation of a PTFE covered stent (vVPASSTM) was feasible and associated with significant
preservation of regional myocardial function during acute ischemia in pigs at reasonable
levels of mean coronary venous pressure to avoid tissue damage during chronic applica-
tion.
1081-62 Potential Impact of Frame Bias Upon Quantitative 
Coronary Angiographic Outcomes in Coronary Stent 
Trials
Tim A. Fischell, Rubina Mirza, Scott Haller, Jeffery J. Popma, Borgess Medical Center, 
Kalamazoo, MI
Background: Study the effects of biased frame selection upon the outcomes from quan-
titative coronary angiography (QCA) in acute and follow-up stent evaluation.
Methods: 39 patients with single vessel stenting and follow-up angiogram at 6 months
were studied using the CMS Medis QCA system. Three different stent types [ A (n=13), B
(n=13), C (n=13)] were compared. Stent groups were similar with respect to demograph-
ics and lesion profile. The acute and follow-up films were read in 3 diferent ways; 1) frame
chosen that makes the stent look most narrowed (Worst); 2) frame chosen that makes
the stent look least narrowed (Best) and 3) the mean value from 3 consecutive end-dias-
tolic frames, as read by unbiased core lab technicians (Core). Immediate and follow-up
mean % diameter stenosis, binary restenosis rates, and late loss were calculated.
Results: The results from the pooled data from all 39 stents were compared using the
Best, Worst and Core lab analysis. Analysis of variance was used to calculate the p val-
ues. The results are shown in the table below.* Best vs. Worst p<0.01; § Best or Worst
vs. Core p< 0.01; ¥- p< 0.001 for Best of A, B or C, vs. Worst of comparison stents.
Conclusions: Significant alteration of angiographic results can be observed with QCA if
operators have a study bias and are given the freedom to choose which angiographic
frame to analyse. These findings underscore the importance of an independent and
blinded core lab analysis in the interpretation of stent trial results. 
